US defense company Leidos Holdings Inc sets an ambitious full-year profit target that surpasses expectations amid high geopolitical tensions, benefiting ...
KalVista Pharmaceuticals achieves key goals in late-stage study for hereditary angioedema therapy, demonstrating significant efficacy of sebetralstat. FDA approval filing ...